Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2008 1
2010 1
2011 1
2014 1
2015 1
2016 1
2017 3
2018 4
2019 3
2020 7
2021 4
2022 4
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
KESTREL and KITE: 52-Week Results From Two Phase III Pivotal Trials of Brolucizumab for Diabetic Macular Edema.
Brown DM, Emanuelli A, Bandello F, Barranco JJE, Figueira J, Souied E, Wolf S, Gupta V, Ngah NF, Liew G, Tuli R, Tadayoni R, Dhoot D, Wang L, Bouillaud E, Wang Y, Kovacic L, Guerard N, Garweg JG. Brown DM, et al. Among authors: ngah nf. Am J Ophthalmol. 2022 Jun;238:157-172. doi: 10.1016/j.ajo.2022.01.004. Epub 2022 Jan 14. Am J Ophthalmol. 2022. PMID: 35038415 Free article. Clinical Trial.
Current practice in the management of ocular toxoplasmosis.
Yogeswaran K, Furtado JM, Bodaghi B, Matthews JM; International Ocular Toxoplasmosis Study Group; Smith JR. Yogeswaran K, et al. Br J Ophthalmol. 2023 Jul;107(7):973-979. doi: 10.1136/bjophthalmol-2022-321091. Epub 2022 Feb 23. Br J Ophthalmol. 2023. PMID: 35197262
Eye health indicators for universal health coverage: results of a global expert prioritisation process.
McCormick I, Mactaggart I, Resnikoff S, Muirhead D, Murthy GV, Silva JC, Bastawrous A, Stern J, Blanchet K, Wang N, Yusufu M, Cooper A, Gichangi M; Eye Health Indicators Prioritisation Project Group; Burton MJ, Ramke J. McCormick I, et al. Br J Ophthalmol. 2022 Jul;106(7):893-901. doi: 10.1136/bjophthalmol-2020-318481. Epub 2021 Mar 12. Br J Ophthalmol. 2022. PMID: 33712481 Free PMC article. Review.
Fenofibrate for the prevention of progression of non-proliferative diabetic retinopathy: review, consensus recommendations and guidance for clinical practice.
Ngah NF, Muhamad NA, Abdul Aziz RA, Mohamed SO, Ahmad Tarmizi NA, Adnan A, Asnir ZZ, Hussein Z, Siew HF, Mohamed M, Lodz NA, Valayatham V. Ngah NF, et al. Int J Ophthalmol. 2022 Dec 18;15(12):2001-2008. doi: 10.18240/ijo.2022.12.16. eCollection 2022. Int J Ophthalmol. 2022. PMID: 36536974 Free PMC article. Review.
HbA1c and retinal sensitivity in diabetics using microperimetry.
Sharanjeet-Kaur, Ismail SA, Mutalib HA, Ngah NF. Sharanjeet-Kaur, et al. Among authors: ngah nf. J Optom. 2019 Jul-Sep;12(3):174-179. doi: 10.1016/j.optom.2018.03.007. Epub 2018 May 26. J Optom. 2019. PMID: 29843983 Free PMC article.
Descriptive assessment on diabetic retinopathy screening in an awareness programme in Malaysia.
Ngah NF, Muhamad NA, Asnir ZZ, Abdul Aziz RA, Mhad Kassim Z, Sahar SA, Ahmad Tarmidzi NA, Chan LY, Uthman R, Satar N, Husain NZ, Adnan A, Kayalakakathu JM, Kadas B, Mohamad NS, Kassim SA. Ngah NF, et al. Int J Ophthalmol. 2020 Nov 18;13(11):1808-1813. doi: 10.18240/ijo.2020.11.19. eCollection 2020. Int J Ophthalmol. 2020. PMID: 33215014 Free PMC article.
35 results